湖北中医药大学学报
湖北中醫藥大學學報
호북중의약대학학보
JOURNAL OF HUBEI UNIVERSITY OF CHINESE MEDICINE
2015年
4期
15-18
,共4页
罗运环%高学清%魏森%李良明%陆付耳
囉運環%高學清%魏森%李良明%陸付耳
라운배%고학청%위삼%리량명%륙부이
非酒精性脂肪肝%胰岛素抵抗%交泰丸%内脏脂肪素
非酒精性脂肪肝%胰島素牴抗%交泰汍%內髒脂肪素
비주정성지방간%이도소저항%교태환%내장지방소
nonalcoholic fatty liver disease%insulin resistance%Jiaotai pill%visfatin
目的:观察交泰丸治疗非酒精性脂肪肝( NAFLD)的疗效。方法将60例NAFLD患者随机分为对照组和治疗组,两组在同等生活行为方式干预基础上分别口服力平之和交泰丸治疗,疗程均为3个月,观察两组的临床疗效及治疗前后的体重、肝功能( ALT、AST、γ-GT)、血脂( TC、TG、HDL-C、LDL-C)、游离脂肪酸( FFA)、内脏脂肪素(Visfatin)、胰岛素抵抗指数(HOMA-RI)、肝脏B超的变化。结果治疗组总有效率优于对照组(P<0.05);治疗组体重、血脂、FFA、Visfatin及HOMA-RI均较本组治疗前下降(P<0.05或P<0.01),肝脏B超显示脂肪变性减轻(P<0.05),与对照组比较,差异均有统计学意义(P<0.05,P <0.01)。结论交泰丸治疗NAFLD疗效肯定,能减轻NAFLD患者的体重,改善脂质代谢紊乱,降低血清Visfatin,减轻肝脏脂肪变性,作用机制可能与改善胰岛素抵抗有关。
目的:觀察交泰汍治療非酒精性脂肪肝( NAFLD)的療效。方法將60例NAFLD患者隨機分為對照組和治療組,兩組在同等生活行為方式榦預基礎上分彆口服力平之和交泰汍治療,療程均為3箇月,觀察兩組的臨床療效及治療前後的體重、肝功能( ALT、AST、γ-GT)、血脂( TC、TG、HDL-C、LDL-C)、遊離脂肪痠( FFA)、內髒脂肪素(Visfatin)、胰島素牴抗指數(HOMA-RI)、肝髒B超的變化。結果治療組總有效率優于對照組(P<0.05);治療組體重、血脂、FFA、Visfatin及HOMA-RI均較本組治療前下降(P<0.05或P<0.01),肝髒B超顯示脂肪變性減輕(P<0.05),與對照組比較,差異均有統計學意義(P<0.05,P <0.01)。結論交泰汍治療NAFLD療效肯定,能減輕NAFLD患者的體重,改善脂質代謝紊亂,降低血清Visfatin,減輕肝髒脂肪變性,作用機製可能與改善胰島素牴抗有關。
목적:관찰교태환치료비주정성지방간( NAFLD)적료효。방법장60례NAFLD환자수궤분위대조조화치료조,량조재동등생활행위방식간예기출상분별구복력평지화교태환치료,료정균위3개월,관찰량조적림상료효급치료전후적체중、간공능( ALT、AST、γ-GT)、혈지( TC、TG、HDL-C、LDL-C)、유리지방산( FFA)、내장지방소(Visfatin)、이도소저항지수(HOMA-RI)、간장B초적변화。결과치료조총유효솔우우대조조(P<0.05);치료조체중、혈지、FFA、Visfatin급HOMA-RI균교본조치료전하강(P<0.05혹P<0.01),간장B초현시지방변성감경(P<0.05),여대조조비교,차이균유통계학의의(P<0.05,P <0.01)。결론교태환치료NAFLD료효긍정,능감경NAFLD환자적체중,개선지질대사문란,강저혈청Visfatin,감경간장지방변성,작용궤제가능여개선이도소저항유관。
s:Objective To analysis the clinical efficacy of Jiaotai pill in treatment of nonalcoholic fatty liver disease( NAFLD) .Meth-ods 60patientswithNAFLDwererandomlydividedintotreatmentgroupandthecontrolgroup.Twogroupsweregiventhesamelifeinter-vention, plus lipantyl and Jiaotai pill respectively.Clinicial efficacy body weight, hepatic function, blood lipids includingtotal cholesterol (TC), triglyceride(TG),high density lipoprotein-cholesterol (HDL-C) and low density lipoprotein-cholesterol (LDL-C), plasma lev-els of free fatty acid (FFA), homeostasis model assessment-insulin resistance index( HOMA-RI), serum Visfatin and liver ultrasonic were detected before and at the end of the three months’ treatment.Results Total effective rate of treatment group was superior to that of control group(P<0.05).Body weight, blood lipids ,FFA,serum Visfatin and HOMA-RI of treatment group were decreased significantly( P<0.05, P<0.01).Liver ultrasonic of treatment group was also improved significantly( P<0.05).Compared with control group, the differences were statistically significant( P<0.05, P<0.01).Conclusion Jiaotai pill in treatment of NAFLD has significantly clinical ef-ficacy,it is suggested that body weight,disturbances of lipids metabolism and hepatic fattydegeneration were improved.The therapeutic mecha-nism might be related to improving insulin resistance.